Dong Song Wei
Unternehmenssekretär bei SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
Vermögen: 30 049 $ am 30.04.2024
Aktive Positionen von Dong Song Wei
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Unternehmenssekretär | 09.01.2012 | - |
| Corporate Officer/Principal | 18.08.2011 | 09.01.2012 | |
Sinopharm YiXin Pharmaceutical Co., Ltd.
 Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Dong Song Wei
Statistik
International
| China | 3 |
Operativ
| Corporate Officer/Principal | 1 |
| Corporate Secretary | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sinopharm YiXin Pharmaceutical Co., Ltd.
Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Health Technology |
- Börse
- Insiders
- Dong Song Wei
- Erfahrung
